Judy Felgenhauer
Pediatric Hematology-Oncology · Spokane, WANPI 1386631059
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.7% of the total across 14 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 10 manufacturers, the largest accounting for just 21.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $390 and has fallen 87.7% since, to $48 in 2025.
Across 14 payments — averaging $80.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$243
- Jazz Pharmaceuticals Inc.$168
- Adaptive Biotechnologies Corporation$125
- Servier Pharmaceuticals LLC$125
- Takeda Pharmaceuticals U.S.A., Inc.$125
- Foundation Medicine, Inc.$123
- plus $215 from 4 others
Across 93 payments — averaging $10,101 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Jazz Pharmaceuticals Inc.$755K
- Boehringer Ingelheim$85K
- E.r. Squibb & Sons, L.L.C.$61K
- Novo Nordisk AS$16K
- Boehringer Ingelheim Pharma GmbH & Co.kg$12K
- Incyte Corporation$8K
- plus $2K from 2 others
What the payments were for
- Food & beverage$1,07596%
- Education$484%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 2 | $243 |
| Jazz Pharmaceuticals Inc. | 3 | $168 |
| Adaptive Biotechnologies Corporation | 2 | $125 |
| Servier Pharmaceuticals LLC | 1 | $125 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $125 |
| Foundation Medicine, Inc. | 1 | $123 |
| Neuronetics, Inc. | 1 | $97 |
| Octapharma USA, Inc. | 1 | $55 |
| Sobi, Inc | 1 | $48 |
| Emmaus Medical, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- KOSELUGO$243
- ADVATE$125
- RYLAZE$125
- FOUNDATIONONE$123
- FOUNDATIONONE HEME$123
- FOUNDATIONONE CDX$123
- FOUNDATIONFOCUS$123
- FOUNDATIONONE LIQUID CDX$123
- clonoSEQ$105
How this compares
$1,123 in reported general payments places this provider in the 65th percentile of 60 pediatric hematology-oncology providers in Washington.
See all pediatric hematology-oncology providers in Washington →
Other pediatric hematology-oncology in Spokane
- Emily HuschartSpokane$1K
- Angela Trobaugh LatrarioSpokane$975
- Stefanos IntzesSpokane$450
- Bar DevaldSpokane$219
- Carrie LabordeSpokane$192
- David GoshornSpokane$15
- Allison WheelerSeattle$318K
- Rebecca JohnsonTacoma$278K
- Rachel RauSeattle$87K
- Paul CarpenterSeattle$40K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.